Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

MyNCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1981 1
1982 2
1983 22
1984 56
1985 60
1986 86
1987 65
1988 108
1989 148
1990 169
1991 211
1992 255
1993 226
1994 306
1995 426
1996 414
1997 388
1998 439
1999 466
2000 418
2001 447
2002 447
2003 397
2004 378
2005 449
2006 318
2007 230
2008 214
2009 217
2010 204
2011 202
2012 197
2013 151
2014 177
2015 169
2016 143
2017 135
2018 108
2019 65
2020 2
Text availability
Article attribute
Article type
Publication date

Search Results

8,616 results
Results by year
Filters applied: . Clear all
Page 1
Comparative effectiveness and tolerability of esomeprazole and omeprazole in gastro-esophageal reflux disease: A systematic review and meta-analysis.
Qi Q, et al. Int J Clin Pharmacol Ther 2015 - Review. PMID 26329348
This study aims to evaluate the effectiveness and tolerability of esomeprazole and omeprazole in patients with gastroesophageal reflux disease (GERD). ...These results revealed a significant difference between esomeprazole vs. omeprazole (RR=1.06, 95% CI [1.01, 1.10], I2=72%, p=0.01) by subgroup according to dosage by random effects model, and a significant difference between esomeprazole 40 mg vs. omeprazole 20 mg (RR=1.07, 95% CI [1.004, 1.14], I2=78%, p=0.04) based on healing rate as determined by endoscopy, using a random effects model. ...
This study aims to evaluate the effectiveness and tolerability of esomeprazole and omeprazole in patients with gastroesophageal reflu …
Safety assessment of omeprazole use: a review.
Forgerini M, et al. Sao Paulo Med J 2018 - Review. PMID 30892487 Free article.
BACKGROUND: Risks regarding hospital admission due to adverse drug reactions and drug interactions from use of omeprazole have been reported. ...It was also proposed to evaluate the safety of use of omeprazole. DESIGN AND SETTING: Qualitative narrative review with critical evaluation, in a public university. ...
BACKGROUND: Risks regarding hospital admission due to adverse drug reactions and drug interactions from use of omeprazole have been r …
Efficacy of omeprazole/sodium bicarbonate treatment in gastroesophageal reflux disease: a systematic review.
Higuera-de-la-Tijera F. Medwave 2018 - Review. PMID 29547594 Spanish, English.
And another study compared omeprazole/sodium bicarbonate/alginate versus omeprazole. In total, there was no difference between omeprazole/sodium bicarbonate and omeprazole. ...CONCLUSION: Omeprazole/sodium bicarbonate therapy is not more effective than omeprazole in the treatment of gastroesophageal reflux disease. ...
And another study compared omeprazole/sodium bicarbonate/alginate versus omeprazole. In total, there was no difference between …
Reliving 25 years of Experience with Omeprazole in Acid-peptic Diseases.
Sharma P. J Assoc Physicians India 2018. PMID 31324090
Omeprazole is a well-established and most studied drug in the PPI class. OBJECTIVES AND METHODS: This review is an objective overview of the efficacy and safety of PPIs in APDs, with special focus on omeprazole. ...CONCLUSION: Twenty five years after the introduction of omeprazole, the first of the PPIs, omeprazole has still remained a valuable drug in the armamentarium of clinicians....
Omeprazole is a well-established and most studied drug in the PPI class. OBJECTIVES AND METHODS: This review is an objective overview
Randomised, double-blind, placebo-controlled pilot trial of omeprazole in idiopathic pulmonary fibrosis.
Dutta P, et al. Thorax 2019 - Clinical Trial. PMID 30610155 Free PMC article.
This study aimed to determine the feasibility of a larger, multicentre trial of omeprazole for cough in IPF, to assess safety and to quantify cough. ...Omeprazole was well tolerated and adverse event profiles were similar in both groups, although there was a small excess of lower respiratory tract infection and a small fall in forced expiratory volume and forced vital capacity associated with omeprazole. ...
This study aimed to determine the feasibility of a larger, multicentre trial of omeprazole for cough in IPF, to assess safety and to …
A pharmacokinetic model of drug-drug interaction between clopidogrel and omeprazole at CYP2C19 in humans.
Tangamornsuksan W, et al. Conf Proc IEEE Eng Med Biol Soc 2017. PMID 29060457
Omeprazole is a proton pump inhibitor used for decreasing gastric acid production. Omeprazole is known to be a potent inhibitor of CYP2C19. ...Six studies were selected into our modeling purposes to develop 3 mathematical models (i.e. 4 studies for clopidogrel alone, 1 study for omeprazole alone and 1 study for clopidogrel-omeprazole interaction). ...
Omeprazole is a proton pump inhibitor used for decreasing gastric acid production. Omeprazole is known to be a potent inhibito
[Antibiotics and omeprazole].
Mamianetti A. Medicina (B Aires) 2018. PMID 29360084 Spanish. Free article.
The effects of clopidogrel and omeprazole on platelet function in normal dogs.
Thames BE, et al. J Vet Pharmacol Ther 2017 - Clinical Trial. PMID 27452307 Free PMC article.
Our objective was to determine the effects of omeprazole and clopidogrel on platelet function in healthy dogs. A crossover study utilized turbidimetric aggregometry (ADP and collagen) and the PFA-100(®) with the collagen/ADP cartridge to evaluate platelet function in eight healthy dogs during the administration of clopidogrel (1 mg/kg/24 h p.o.), omeprazole (1 mg/kg/24 h p.o.), and a combination of clopidogrel and omeprazole. ...When compared to the clopidogrel group, clopidogrel metabolite concentrations in the clopidogrel/omeprazole group were significantly higher on Days 3 and 5. ...
Our objective was to determine the effects of omeprazole and clopidogrel on platelet function in healthy dogs. A crossover study util …
Re-evaluation of the regulation of omeprazole in racehorses: An evidence-based approach.
Viljanto M, et al. J Vet Pharmacol Ther 2018. PMID 29468684
This ensures that horses do not compete under the influence of any drugs, including omeprazole, a therapeutic medication used to treat equine gastric ulcer syndrome. In this study, pharmacokinetic data were produced in equine plasma and urine following an oral administration of 4 mg/kg of generic buffered formulation of omeprazole to six Thoroughbred horses in five daily doses to determine an appropriate screening limit and detection time in equine plasma and to assess whether the current detection time of 72 hr in equine urine would be applicable when an alternative omeprazole product is administered. ...
This ensures that horses do not compete under the influence of any drugs, including omeprazole, a therapeutic medication used to trea …
8,616 results
Jump to page
Feedback